Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan

Hepatology Research

Volumn 38, Issue 5, 2008, Pages 457-464

  Kurbanov, Fuat ^a,b   Tanaka, Yasuhito ^a   Avazova, Dildora ^b   Khan, Anis ^a   Sugauchi, Fuminaka ^a   Kan, Nataliya ^b   Kurbanova khudayberganova, Dinara ^b   Khikmatullaeva, Aziza ^b   Musabaev, Erkin ^b   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Ministry of Public Health   (Uzbekistan)

Author keywords

2k 1b; HCV; HCV genotyping; Natural recombination

Indexed keywords

ADULT; ARTICLE; ASIA; COHORT ANALYSIS; CONTROLLED STUDY; CROSSING OVER; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; UZBEKISTAN; VIRUS DETECTION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS STRAIN;

EID: 42649083676     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00293.x     Document Type: Article

References (25)

1. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13: 223-35.
2. Simmonds P, Bukh J, Combet C et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-73.
3. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: A systematic review. JAMA 2007; 297: 724-32.
4. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002; 76: 4034-43.
5. Kageyama S, Agdamag DM, Alesna ET et al. A natural inter-genotypic (2b/ 1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006; 78: 1423-8.
6. Moreau I, Hegarty S, Levis J et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J 2006; 3: 95.
7. Legrand-Abravanel F, Claudinon J, Nicot F et al. A new natural intergenotypic (2/5) recombinant of Hepatitis C virus. J Virol 2007 [A19]; 81(8): 4357-62.
8. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006; 80: 7569-77.
9. Gao F, Nainan OV, Khudyakov Y et al. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol 2007; 88: 143-7.
10. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 2004; 190: 1396-403.
11. Micallef JM, Macdonald V, Jauncey M et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat 2007; 14: 413-18.
12. Takeuchi T, Katsume A, Tanaka T et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999; 116: 636-42.
13. Ohno O, Mizokami M, Wu RR et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 201-7.
14. Hashimoto M, Chayama K, Tubota A et al. Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region. Int Hepatol Comms 1996; 4: 263-7.
15. Tanaka Y, Hanada K, Mizokami M et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 2002; 99: 15584-9.
16. Kuiken C, Mizokami M, Deleage G et al. Hepatitis C databases, principles and utility to researchers. Hepatology 2006; 43: 1157-65.
17. Kalinina O, Norder H, Magnius LO. Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: Proposed mechanism for its formation. J Gen Virol 2004; 85: 1853-7.
18. Samokhvalov EI, Hijikata M, Gylka RI, Lvov DK, Mishiro S. Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k). Virus Genes 2000; 20: 183-7.
19. Tallo T, Norder H, Tefanova V et al. Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time. J Med Virol 2007; 79: 374-82.
20. Kurbanov F, Tanaka Y, Sugauchi F et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003; 69: 367-75.
21. Shustov AV, Kochneva GV, Sivolobova GF et al. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 2005; 77: 382-9.
22. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis 2007; 195: 519-24.
23. Buckton AJ, Ngui SL, Arnold C et al. Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes. J Clin Microbiol 2006; 44: 2779-84.
24. Tscherne DM, Evans MJ, von Hahn T et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007; 81: 3693-703.
25. Schaller T, Appel N, Koutsoudakis G et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007; 81: 4591-603.